Filed: 5/15/2024ACC: 0001104659-24-061943
📋 What this filing means
NORTHPOND VENTURES, LLC filed this quarterly 13F‑HR report disclosing 4 equity positions with a total reported market value of $102.63M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
4
Positions
$102.63M
Total AUM (reported)
19.25M
Total Shares
Allocation by class
COM$102.63M100.0%
Portfolio Concentration
Top 3$99.57M97.0%
4–10$3.06M3.0%
Top 3 weight
97.0%
Top 10 weight
100.0%
Voting Authority Distribution
Total shares with voting rights: 19.25M
Sole
Full voting authority
19.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole4
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings4
Rows:
KYVERNA THERAPEUTICS INC
SOLEShares3.26M
TypeSH
Market value$80.86M
78.80%
Sole
3.26M
Shared
0.00
None
0.00
VIGIL NEUROSCIENCE INC
SOLEShares4.21M
TypeSH
Market value$14.37M
14.00%
Sole
4.21M
Shared
0.00
None
0.00
TELESIS BIO INC
SOLEShares9.84M
TypeSH
Market value$4.33M
4.22%
Sole
9.84M
Shared
0.00
None
0.00
CANDEL THERAPEUTICS INC
SOLEShares1.94M
TypeSH
Market value$3.06M
2.98%
Sole
1.94M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KYVERNA THERAPEUTICS INCSOLE | COM | 3.26M | SH | $80.86M 78.80% | 3.26M | 0.00 | 0.00 |
VIGIL NEUROSCIENCE INCSOLE | COM | 4.21M | SH | $14.37M 14.00% | 4.21M | 0.00 | 0.00 |
TELESIS BIO INCSOLE | COM | 9.84M | SH | $4.33M 4.22% | 9.84M | 0.00 | 0.00 |
CANDEL THERAPEUTICS INCSOLE | COM | 1.94M | SH | $3.06M 2.98% | 1.94M | 0.00 | 0.00 |